Skip to main content
. 2017 May 4;8(30):49329–49337. doi: 10.18632/oncotarget.17632

Table 1. Characteristics of the patient population.

Patients Hormone Sensitive Castration Resistant
n = 48 10 (20.83%) 38 (79.17%)
Gleason 6–7 (3 + 4) 3 (30.00%) 3 (7.89%)
Gleason 7 (4 + 3)–9 6 (60.00%) 26 (68.42%)
84-1 CTC Positive 6 31
CellSearch CTC Positive 5 24
Met Sites Hormone Sensitive Castration Resistant
Bone 8 35
Lymph nodes 5 20
Liver 2 4
Lung 1 2
Age Hormone Sensitive Castration Resistant
Mean 69.1 65.92
Median 69.5 67
Range 62–76 49–83
PSA Hormone Sensitive Castration Resistant
Mean 20.5 128.46
Median 9.15 24.25
Range 0.1–97.3 0.6–1442.2